These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37104226)

  • 1. Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients-When Intravesical Botox Injection or Urethral Botox Injection Are Indicated.
    Chen PC; Lee KH; Lee WC; Yeh TC; Kuo YC; Chiang BJ; Liao CH; Meng E; Kao YL; Lee YC; Kuo HC
    Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
    Kuo HC
    Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.
    Lee CL; Jhang JF; Jiang YH; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
    Denys P; Castaño Botero JC; Vita Nunes RL; Wachs B; Mendes Gomes C; Krivoborodov G; Tu LM; Del-Popolo G; Thompson C; Vilain C; Volteau M; Kennelly M;
    Neurourol Urodyn; 2023 Jan; 42(1):153-167. PubMed ID: 36321799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
    Chen SF; Jiang YH; Jhang JF; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.
    Linsenmeyer TA
    J Spinal Cord Med; 2013 Sep; 36(5):402-19. PubMed ID: 23941788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
    Chen YC; Kuo HC
    Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
    Chen G; Liao L
    Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury.
    Chen H; Xie K; Jiang C
    J Spinal Cord Med; 2021 Sep; 44(5):757-764. PubMed ID: 32003644
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries.
    Kuo HC; Liu SH
    Neurourol Urodyn; 2011 Nov; 30(8):1541-5. PubMed ID: 21717505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
    Lee YK; Kuo HC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection?
    Chow PM; Kuo HC
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.
    Chen SF; Chang CH; Kuo HC
    Spinal Cord; 2016 Oct; 54(10):889-894. PubMed ID: 26832760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
    Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.
    Ginsberg D; Cruz F; Herschorn S; Gousse A; Keppenne V; Aliotta P; Sievert KD; Brin MF; Jenkins B; Thompson C; Lam W; Heesakkers J; Haag-Molkenteller C
    Adv Ther; 2013 Sep; 30(9):819-33. PubMed ID: 24072665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.